Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
The latest announcement is out from Evolent Health ( (EVH) ).
Evolent Health announced its upcoming presentation at the 43rd Annual J.P. Morgan Healthcare Conference, highlighting its financial outlook and strategic direction. The company aims for significant revenue growth and improved Adjusted EBITDA through updated Performance Suite contracts and expansions in T&S solutions, despite facing industry challenges such as plan terminations and rising oncology costs.
More about Evolent Health
Evolent Health, Inc. operates within the healthcare industry, providing a range of services focused on improving clinical and financial outcomes for healthcare providers and health plans. Its primary offerings include solutions for managing total cost of care and performance-based contracts, as well as technology and service (T&S) solutions.
YTD Price Performance: 9.14%
Average Trading Volume: 2,594,241
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $1.46B
See more insights into EVH stock on TipRanks’ Stock Analysis page.
